Hyperliquid Strategies Inc

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.